Home Healthcare Biotechnology Rare Disease Genetic Testing Market

Rare Disease Genetic Testing Market Size, Share & Trends Analysis Report By Disease Type (Immunological Disorders, Cardiovascular Disorders, Neurological Disease, Endocrine and Metabolism Disorders Diseases, Hematological Diseases, Dermatological Disease, Others), By Specialty (Molecular Genetic Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests), By Technology (Next-Generation Sequencing, Sanger Sequencing, PCR Based Testing, Array Based Testing, FISH, Others), By End-User (Hospitals and Clinics, Research Laboratories and CROs, Diagnostic Laboratories) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format: | Report Code: SR4609DR | Pages: 155
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Rare Disease Genetic Testing Market, By Disease Type 2022-2034 (USD MILLION/ Units)
    1. Immunological Disorders
    2. Cardiovascular Disorders
    3. Neurological Disease
    4. Endocrine and Metabolism Disorders Diseases
    5. Hematological Diseases
    6. Dermatological Disease
    7. Others
  2. Rare Disease Genetic Testing Market, By Specialty 2022-2034 (USD MILLION/ Units)
    1. Molecular Genetic Tests
    2. Chromosomal Genetic Tests
    3. Biochemical Genetic Tests
  3. Rare Disease Genetic Testing Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Next-Generation Sequencing
    2. Sanger Sequencing
    3. PCR Based Testing
    4. Array Based Testing
    5. FISH
    6. Others
  4. Rare Disease Genetic Testing Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals and Clinics
    2. Research Laboratories and CROs
    3. Diagnostic Laboratories
  5. Regional Rare Disease Genetic Testing Market
    1. North America
      1. North America Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Immunological Disorders
        2. Cardiovascular Disorders
        3. Neurological Disease
        4. Endocrine and Metabolism Disorders Diseases
        5. Hematological Diseases
        6. Dermatological Disease
        7. Others
      2. North America Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
        1. Molecular Genetic Tests
        2. Chromosomal Genetic Tests
        3. Biochemical Genetic Tests
      3. North America Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing
        2. Sanger Sequencing
        3. PCR Based Testing
        4. Array Based Testing
        5. FISH
        6. Others
      4. North America Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Research Laboratories and CROs
        3. Diagnostic Laboratories
      5. U.S. Rare Disease Genetic Testing Market
        1. U.S. Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. U.S. Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. U.S. Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. U.S. Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      6. Canada Rare Disease Genetic Testing Market
        1. Canada Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Canada Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Canada Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Canada Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
    2. Europe
      1. Europe Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Immunological Disorders
        2. Cardiovascular Disorders
        3. Neurological Disease
        4. Endocrine and Metabolism Disorders Diseases
        5. Hematological Diseases
        6. Dermatological Disease
        7. Others
      2. Europe Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
        1. Molecular Genetic Tests
        2. Chromosomal Genetic Tests
        3. Biochemical Genetic Tests
      3. Europe Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing
        2. Sanger Sequencing
        3. PCR Based Testing
        4. Array Based Testing
        5. FISH
        6. Others
      4. Europe Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Research Laboratories and CROs
        3. Diagnostic Laboratories
      5. U.K. Rare Disease Genetic Testing Market
        1. U.K. Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. U.K. Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. U.K. Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. U.K. Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      6. Germany Rare Disease Genetic Testing Market
        1. Germany Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Germany Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Germany Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Germany Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      7. France Rare Disease Genetic Testing Market
        1. France Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. France Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. France Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. France Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      8. Spain Rare Disease Genetic Testing Market
        1. Spain Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Spain Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Spain Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Spain Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      9. Italy Rare Disease Genetic Testing Market
        1. Italy Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Italy Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Italy Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Italy Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      10. Russia Rare Disease Genetic Testing Market
        1. Russia Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Russia Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Russia Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Russia Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      11. Nordic Rare Disease Genetic Testing Market
        1. Nordic Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Nordic Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Nordic Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Nordic Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      12. Benelux Rare Disease Genetic Testing Market
        1. Benelux Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Benelux Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Benelux Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Benelux Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      13. Rest of Europe Rare Disease Genetic Testing Market
        1. Rest of Europe Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Rest of Europe Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Rest of Europe Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Rest of Europe Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
    3. APAC
      1. APAC Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Immunological Disorders
        2. Cardiovascular Disorders
        3. Neurological Disease
        4. Endocrine and Metabolism Disorders Diseases
        5. Hematological Diseases
        6. Dermatological Disease
        7. Others
      2. APAC Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
        1. Molecular Genetic Tests
        2. Chromosomal Genetic Tests
        3. Biochemical Genetic Tests
      3. APAC Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing
        2. Sanger Sequencing
        3. PCR Based Testing
        4. Array Based Testing
        5. FISH
        6. Others
      4. APAC Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Research Laboratories and CROs
        3. Diagnostic Laboratories
      5. China Rare Disease Genetic Testing Market
        1. China Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. China Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. China Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. China Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      6. Korea Rare Disease Genetic Testing Market
        1. Korea Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Korea Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Korea Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Korea Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      7. Japan Rare Disease Genetic Testing Market
        1. Japan Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Japan Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Japan Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Japan Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      8. India Rare Disease Genetic Testing Market
        1. India Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. India Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. India Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. India Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      9. Australia Rare Disease Genetic Testing Market
        1. Australia Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Australia Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Australia Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Australia Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      10. Taiwan Rare Disease Genetic Testing Market
        1. Taiwan Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Taiwan Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Taiwan Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Taiwan Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      11. South East Asia Rare Disease Genetic Testing Market
        1. South East Asia Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. South East Asia Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. South East Asia Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. South East Asia Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      12. Rest of Asia-Pacific Rare Disease Genetic Testing Market
        1. Rest of Asia-Pacific Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Rest of Asia-Pacific Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Rest of Asia-Pacific Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Rest of Asia-Pacific Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
    4. Middle East and Africa
      1. Middle East and Africa Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Immunological Disorders
        2. Cardiovascular Disorders
        3. Neurological Disease
        4. Endocrine and Metabolism Disorders Diseases
        5. Hematological Diseases
        6. Dermatological Disease
        7. Others
      2. Middle East and Africa Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
        1. Molecular Genetic Tests
        2. Chromosomal Genetic Tests
        3. Biochemical Genetic Tests
      3. Middle East and Africa Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing
        2. Sanger Sequencing
        3. PCR Based Testing
        4. Array Based Testing
        5. FISH
        6. Others
      4. Middle East and Africa Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Research Laboratories and CROs
        3. Diagnostic Laboratories
      5. UAE Rare Disease Genetic Testing Market
        1. UAE Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. UAE Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. UAE Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. UAE Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      6. Turkey Rare Disease Genetic Testing Market
        1. Turkey Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Turkey Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Turkey Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Turkey Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      7. Saudi Arabia Rare Disease Genetic Testing Market
        1. Saudi Arabia Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Saudi Arabia Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Saudi Arabia Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Saudi Arabia Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      8. South Africa Rare Disease Genetic Testing Market
        1. South Africa Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. South Africa Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. South Africa Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. South Africa Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      9. Egypt Rare Disease Genetic Testing Market
        1. Egypt Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Egypt Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Egypt Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Egypt Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      10. Nigeria Rare Disease Genetic Testing Market
        1. Nigeria Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Nigeria Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Nigeria Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Nigeria Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      11. Rest of MEA Rare Disease Genetic Testing Market
        1. Rest of MEA Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Rest of MEA Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Rest of MEA Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Rest of MEA Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
    5. LATAM
      1. LATAM Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Immunological Disorders
        2. Cardiovascular Disorders
        3. Neurological Disease
        4. Endocrine and Metabolism Disorders Diseases
        5. Hematological Diseases
        6. Dermatological Disease
        7. Others
      2. LATAM Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
        1. Molecular Genetic Tests
        2. Chromosomal Genetic Tests
        3. Biochemical Genetic Tests
      3. LATAM Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing
        2. Sanger Sequencing
        3. PCR Based Testing
        4. Array Based Testing
        5. FISH
        6. Others
      4. LATAM Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Research Laboratories and CROs
        3. Diagnostic Laboratories
      5. Brazil Rare Disease Genetic Testing Market
        1. Brazil Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Brazil Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Brazil Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Brazil Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      6. Mexico Rare Disease Genetic Testing Market
        1. Mexico Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Mexico Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Mexico Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Mexico Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      7. Argentina Rare Disease Genetic Testing Market
        1. Argentina Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Argentina Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Argentina Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Argentina Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      8. Chile Rare Disease Genetic Testing Market
        1. Chile Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Chile Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Chile Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Chile Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      9. Colombia Rare Disease Genetic Testing Market
        1. Colombia Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Colombia Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Colombia Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Colombia Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
      10. Rest of LATAM Rare Disease Genetic Testing Market
        1. Rest of LATAM Rare Disease Genetic Testing Market By Disease Type 2022-2034 (USD MILLION/ Units)
          1. Immunological Disorders
          2. Cardiovascular Disorders
          3. Neurological Disease
          4. Endocrine and Metabolism Disorders Diseases
          5. Hematological Diseases
          6. Dermatological Disease
          7. Others
        2. Rest of LATAM Rare Disease Genetic Testing Market By Specialty 2022-2034 (USD MILLION/ Units)
          1. Molecular Genetic Tests
          2. Chromosomal Genetic Tests
          3. Biochemical Genetic Tests
        3. Rest of LATAM Rare Disease Genetic Testing Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Next-Generation Sequencing
          2. Sanger Sequencing
          3. PCR Based Testing
          4. Array Based Testing
          5. FISH
          6. Others
        4. Rest of LATAM Rare Disease Genetic Testing Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Research Laboratories and CROs
          3. Diagnostic Laboratories
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.